📖
TET2-driven activation of AGO2 links epigenetic remodeling to myeloid commitment and leukemia.
Lazarenkov A, Valcárcel G, Martinez A, Berenguer C, López-Rubio AV, Obiols M, Fontanet C, Barba A, Rodríguez-Sevilla JJ, Stik G, Jeremias I, Menendez P, Sardina JL

TET2-driven activation of AGO2 links epigenetic remodeling to myeloid commitment and leukemia.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Sci Adv.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title TET2-driven activation of AGO2 links epigenetic remodeling to myeloid commitment and leukemia.
Author / Organization Lazarenkov A, Valcárcel G, Martinez A, Berenguer C, López-Rubio AV, Obiols M, Fontanet C, Barba A, Rodríguez-Sevilla JJ, Stik G, Jeremias I, Menendez P, Sardina JL
Subject & Discipline Sci Adv
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-36865
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »